Literature DB >> 23449936

Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammation.

Kechun Tang1, George Murano, Harrieth Wagner, Leonardo Nogueira, Peter D Wagner, Alisa Tang, Nancy D Dalton, Yusu Gu, Kirk L Peterson, Ellen C Breen.   

Abstract

Pulmonary TNFα has been linked to reduced exercise capacity in a subset of patients with moderate to severe chronic obstructive pulmonary disease (COPD). We hypothesized that prolonged, high expression of pulmonary TNFα impairs cardiac and skeletal muscle function, and both contribute to exercise limitation. Using a surfactant protein C promoter-TNFα construct, TNFα was overexpressed throughout life in mouse lungs (SP-C/TNFα+). TNFα levels in wild-type (WT) female serum and lung were two- and threefold higher than in WT male mice. In SP-C/TNFα+ mice, TNFα increased similarly in both sexes. Treadmill exercise was impaired only in male SP-C/TNFα+ mice. While increases in lung volume and airspace size induced by TNFα were comparable in both sexes, pulmonary hypertension along with lower body and muscle mass were evident only in male mice. Left ventricular (LV) function (cardiac output, stroke volume, LV maximal pressure, and LV maximal pressure dP/dt) was not altered by TNFα overexpression. Fatigue measured in isolated soleus and EDL was more rapid only in soleus of male SP-C/TNFα+ mice and accompanied by a loss of oxidative IIa fibers, citrate synthase activity, and PGC-1α mRNA and increase in atrogin-1 and MuRF1 expression also only in male mice. In situ gastrocnemius fatigue resistance, reflecting both oxygen availability and contractility, was decreased similarly in female and male SP-C/TNFα+ mice. These data indicate that male, but not female, mice overexpressing pulmonary TNFα are susceptible to exercise limitation, possibly due to muscle wasting and loss of the oxidative muscle phenotype, with protection in females possibly due to estrogen.

Entities:  

Keywords:  PGC-1; angiopoietin; atrophy; chronic obstructive pulmonary disease; fatigue

Mesh:

Substances:

Year:  2013        PMID: 23449936      PMCID: PMC3656431          DOI: 10.1152/japplphysiol.00607.2012

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  59 in total

1.  Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

Authors:  E C Creutzberg; A M Schols; C A Weling-Scheepers; W A Buurman; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

2.  Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression.

Authors:  László Szalay; Tomoharu Shimizu; Takao Suzuki; Huang-Ping Yu; Mashkoor A Choudhry; Martin G Schwacha; Loring W Rue; Kirby I Bland; Irshad H Chaudry
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-27       Impact factor: 3.619

3.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

Authors:  D Bryant; L Becker; J Richardson; J Shelton; F Franco; R Peshock; M Thompson; B Giroir
Journal:  Circulation       Date:  1998-04-14       Impact factor: 29.690

Review 4.  Aging, traumatic injury, and estrogen treatment.

Authors:  Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2005-07       Impact factor: 4.032

5.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Authors:  Y Miyazaki; K Araki; C Vesin; I Garcia; Y Kapanci; J A Whitsett; P F Piguet; P Vassalli
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  Attenuation of pulmonary hypertension, but not emphysematous change, by breeding emphysema model mice at sea level.

Authors:  Masaki Fujita; Satoshi Ikegame; Qing Ye; Eiji Harada; Hiroshi Ouchi; Ichiro Inoshima; Kentaro Watanabe; Robert J Mason; Yoichi Nakanishi
Journal:  Cytokine       Date:  2008-02-21       Impact factor: 3.861

7.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

8.  TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k.

Authors:  Yi-Ping Li; Stewart H Lecker; Yuling Chen; Ian D Waddell; Alfred L Goldberg; Michael B Reid
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

9.  Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.

Authors:  Vicent Ribas; M T Audrey Nguyen; Darren C Henstridge; Anh-Khoi Nguyen; Simon W Beaven; Matthew J Watt; Andrea L Hevener
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

10.  TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure.

Authors:  Kechun Tang; Peter D Wagner; Ellen C Breen
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

View more
  9 in total

1.  Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofibre calcium kinetics in mice.

Authors:  Leonardo Nogueira; Breanna M Trisko; Frederico L Lima-Rosa; Jason Jackson; Helena Lund-Palau; Masahiro Yamaguchi; Ellen C Breen
Journal:  J Physiol       Date:  2018-06-19       Impact factor: 5.182

2.  Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice.

Authors:  Li Zuo; Allison H Hallman; William J Roberts; Peter D Wagner; Michael C Hogan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-11-06       Impact factor: 3.619

3.  Pamidronate attenuates muscle loss after pediatric burn injury.

Authors:  Elisabet Børsheim; David N Herndon; Hal K Hawkins; Oscar E Suman; Matthew Cotter; Gordon L Klein
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

4.  IL-13-driven pulmonary emphysema leads to skeletal muscle dysfunction attenuated by endurance exercise.

Authors:  Joseph Balnis; Tanner C Korponay; Catherine E Vincent; Diane V Singer; Alejandro P Adam; David Lacomis; Chun Geun Lee; Jack A Elias; Harold A Singer; Ariel Jaitovich
Journal:  J Appl Physiol (1985)       Date:  2019-11-27

Review 5.  Hypercapnic Respiratory Failure-Driven Skeletal Muscle Dysfunction: It Is Time for Animal Model-Based Mechanistic Research.

Authors:  Ariel Jaitovich
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 6.  Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health.

Authors:  Cristina Russo; Maria Stella Valle; Antonino Casabona; Lucia Spicuzza; Gianluca Sambataro; Lucia Malaguarnera
Journal:  Biomedicines       Date:  2022-04-14

7.  Caffeine intake may modulate inflammation markers in trained rats.

Authors:  Rômulo Pillon Barcelos; Mauren Assis Souza; Guilherme Pires Amaral; Silvio Terra Stefanello; Guilherme Bresciani; Michele Rechia Fighera; Félix Alexandre Antunes Soares; Nilda de Vargas Barbosa
Journal:  Nutrients       Date:  2014-04-21       Impact factor: 5.717

8.  Inspiratory muscle training and functional capacity following coronary artery bypass grafting in high-risk patients: A pilot randomized and controlled trial.

Authors:  André Luiz Lisboa Cordeiro; Bianca Silva Cavalcante De Carvalho; Eduarda Gomes Da Silva; Natália Da Silva Santos; Thiago Araújo de Melo; André Raimundo França Guimarães; Jefferson Petto
Journal:  J Clin Transl Res       Date:  2022-06-17

9.  Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Cewin Chao; Eric Vittinghoff; Howard Andrews; Cheng-Shiun Leu
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.